Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

for
Advanced Solid Tumors, Non-Small Cell Lung Cancer
Location: Ohio City OH
Sponsor: Chong Kun Dang Pharmaceutical

Sex: All

Age: 19+

Code: NCT07439094

Phase 1, Phase 2, Recruiting

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Fairfax VA, Denver CO, Sarasota FL, Nashville TN,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07066657

Phase 1, Recruiting

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

for
Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07685938

Phase 2, Recruiting

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

for
Solid Tumor, Renal Cell Cancer Metastatic,
Location: Philadelphia PA, Dallas TX
Sponsor: Eutilex

Sex: All

Age: 18+

Code: NCT04903873

Phase 1, Phase 2, Recruiting

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

for
Advanced Solid Tumor Cancer
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 18+

Code: NCT04777994

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Wearable Devices and Biomarkers Project (Healthiomics)

for
Brain Cancer, Neurological Disorder, Neurological Cancer
Location: San Diego CA
Sponsor: CureScience

Sex: All

Age: 18+

Code: NCT05106725

Recruiting

Endoscopic Resection Multicenter Registry

for
Gastrointestinal Neoplasms, Gastrointestinal Disease,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT03065257

Recruiting

Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

for
Dermatologic Complications,
Location: Harvey IL
Sponsor: Ingalls Memorial Hospital

Sex: All

Age: 18+

Code: NCT00498992

Recruiting

Physician Perceptions About Parenteral Hydration in Latin America and Spain

for
Dehydration, Advanced Cancers
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT01011140

Recruiting

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

for
Solid Malignancies, Hematologic Malignancies
Location: Providence RI, New Haven CT, Charlottesville VA,
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT06823167

Phase 1, Recruiting

Collection and Distribution of Biospecimens for Novel Research Uses

for
Cancer, Healthy, Gastrointestinal Complication,
Location: Huntsville AL
Sponsor: iSpecimen Inc

Sex: All

Age: 0 - 70+

Code: NCT03848962

Recruiting

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

for
CNS Cancer, Head and Neck Cancer, GI Cancer, Gynecologic Cancer,
Location: New York NY
Sponsor: The New York Proton Center

Sex: All

Age: 18+

Code: NCT05313191

Recruiting

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

for
Solid Malignancies
Location: Fairfax VA, Dallas TX, San Antonio TX
Sponsor: Carrick Therapeutics Limited

Sex: All

Age: 18+

Code: NCT06600789

Phase 1, Phase 2, Recruiting

Arizona Cancer Center Biospecimen Repository

for
Cancer
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT00896935

Recruiting

Autologous CAR-T Cells Targeting B7-H3 in PDAC

for
Pancreas Cancer, Relapse, Resistant Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06158139

Phase 1, Recruiting

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

for
Solid Tumors, Hematological Malignancies
Location: Providence RI, East Greenwich RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT02213822

Recruiting

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691517

Phase 1, Recruiting

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

for
Solid Tumors, Adult
Location: Irving TX, San Antonio TX
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Sex: All

Age: 18+

Code: NCT06504368

Phase 1, Recruiting

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

for
Cancer, Tumor, Solid, Refractory Cancer
Location: Los Angeles CA
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT04640246

Phase 1, Phase 2, Recruiting

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

for
Breast Cancer, Relapse, Resistant Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06347068

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial